AXELEREX CORP. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-08-12: Form 8-K; Period of report 2021-08-09; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
- 2021-08-03: Form 8-K/A; Period of report 2021-02-16; Description 9.01 Financial Statements and Exhibits; Details 9.01.
- 2021-07-29: Form 8-K; Period of report 2021-07-26; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
- 2021-05-04: Form 8-K; Period of report 2021-04-28; Description 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2021-08-12 | 8-K | 2021-08-09 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 Effective August 9, 2021, Haynie & Company (“Haynie”) was dismissed as the independent registered public accounting firm of Biosecurity Technology Inc. (the “Company”). | biosecuritytech_8k.htm |
| 2021-08-03 | 8-K/A | 2021-02-16 | 9.01 Financial Statements and Exhibits | 9.01 (a) Financial statements of businesses acquired. | biosecuritytech_8ka1.htm |
| 2021-07-29 | 8-K | 2021-07-26 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 Effective July 26, 2021, PLS, CPA (“PLS”) was dismissed as the independent registered public accounting firm of Biosecurity Technology Inc. (the “Company”). | biosecuritytech_8k.htm |
| 2021-05-04 | 8-K | 2021-04-28 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 Effective April 28, 2021, Biosecurity Technology, Inc., a Nevada corporation (the “Registrant”) entered into a Consulting Agreement (the Agreement”) with Global Food Innovations, LLC a Texas limited liability (the “Consultant”). 3.02 The disclosures set forth in Item 1.01 are hereby incorporated by reference into this Item 5.01. | biosecuritytech_8k.htm |
| 2021-02-26 | 8-K | 2021-02-16 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 1.01 On February 16, 2021, Sergey Peredkov, the former principal shareholder, Chief Executive Officer, Secretary and Director of Biosecurity Technology, Inc., formerly known as Axelerex Corp. (the “Registrant”), consummated the sale of 5,000,000 shares (the “Shares”) of the Registrant’s common stock, par value $0.001 per share (the “Common Stock”) to M3 Equity Partners, LLC (“M3). 2.01 As described in Section 1.01, on February 16, 2021, the Company executed an Agreement and Plan of Merger (as defined earlier as the “Merger Agreement”). 3.02 As disclosed in Item 2.01, which disclosures are hereby incorporated by reference, in connection with the Merger, the Registrant issued an aggregate of 28,000,000 shares of its Common Stock to the equityholders of BST. 5.01 The disclosures set forth in Item 2.01 are hereby incorporated by reference into this Item 5.01. 5.03 On February 16, 2021, the Registrant’s Board of Directors and majority shareholder approved an amendment to the Registrant’s Articles of Incorporation (the “Amendment”) to (i) change the name of the corporation to Biosecurity Technology, Inc. and (ii) to increase the number of its authorized shares of capital stock from 75,000,000 to 110,000,000 shares of which 100,000,000 shares were designated common stock, par value $0.001 per share (the “Common Stock”) and 10,000,000 shares were designated “blank check” preferred stock, par value $0.001 per share (the “Preferred Stock”). | biosecuritytech_8k.htm |